 |
인쇄하기
취소
|
Sanofi-Synthelabo to acquire Keunwha Pharm in 90.0 billion deal
Sanofi-Synthelabo Korea affiliated with the world's largest drug company, Paris-based Sanofi-Synthelabo of France, said on July 29 it signed an agreement with Keunwha Pharm in a bid to acquire the latter's pharmaceutical division.
Under the definitive agreement, Sanofi-Synthelabo Korea will buy the pharmaceutical business of Keunwha Pharm in the form of comprehensive sale assignment in a 90....
Under the definitive agreement, Sanofi-Synthelabo Korea will buy the pharmaceutical business of Keunwha Pharm in the form of comprehensive sale assignment in a 90....
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.